rs28362285

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_174936.4(PCSK9):​c.1869C>T​(p.Thr623Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,613,520 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0048 ( 5 hom., cov: 33)
Exomes 𝑓: 0.00073 ( 3 hom. )

Consequence

PCSK9
NM_174936.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -2.44

Publications

2 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-55063374-C-T is Benign according to our data. Variant chr1-55063374-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 468295.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.44 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00475 (724/152308) while in subpopulation AFR AF = 0.0157 (654/41558). AF 95% confidence interval is 0.0147. There are 5 homozygotes in GnomAd4. There are 349 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.1869C>Tp.Thr623Thr
synonymous
Exon 12 of 12NP_777596.2
PCSK9
NM_001407240.1
c.1992C>Tp.Thr664Thr
synonymous
Exon 13 of 13NP_001394169.1A0AAQ5BGX4
PCSK9
NM_001407241.1
c.1911C>Tp.Thr637Thr
synonymous
Exon 12 of 12NP_001394170.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.1869C>Tp.Thr623Thr
synonymous
Exon 12 of 12ENSP00000303208.5Q8NBP7-1
PCSK9
ENST00000710286.1
c.2226C>Tp.Thr742Thr
synonymous
Exon 12 of 12ENSP00000518176.1A0AA34QVH0
PCSK9
ENST00000713786.1
c.1992C>Tp.Thr664Thr
synonymous
Exon 13 of 13ENSP00000519088.1A0AAQ5BGX4

Frequencies

GnomAD3 genomes
AF:
0.00476
AC:
724
AN:
152190
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0158
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00130
AC:
321
AN:
247582
AF XY:
0.00112
show subpopulations
Gnomad AFR exome
AF:
0.0153
Gnomad AMR exome
AF:
0.000989
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000546
Gnomad FIN exome
AF:
0.0000471
Gnomad NFE exome
AF:
0.000297
Gnomad OTH exome
AF:
0.000824
GnomAD4 exome
AF:
0.000734
AC:
1072
AN:
1461212
Hom.:
3
Cov.:
30
AF XY:
0.000669
AC XY:
486
AN XY:
726882
show subpopulations
African (AFR)
AF:
0.0164
AC:
548
AN:
33468
American (AMR)
AF:
0.00112
AC:
50
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26114
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39676
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86128
European-Finnish (FIN)
AF:
0.0000750
AC:
4
AN:
53358
Middle Eastern (MID)
AF:
0.00175
AC:
10
AN:
5710
European-Non Finnish (NFE)
AF:
0.000312
AC:
347
AN:
1111768
Other (OTH)
AF:
0.00177
AC:
107
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
60
120
181
241
301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00475
AC:
724
AN:
152308
Hom.:
5
Cov.:
33
AF XY:
0.00469
AC XY:
349
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0157
AC:
654
AN:
41558
American (AMR)
AF:
0.00255
AC:
39
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68026
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
39
77
116
154
193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00316
Hom.:
8
Bravo
AF:
0.00526
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
3
Hypercholesterolemia, autosomal dominant, 3 (3)
-
-
2
Familial hypercholesterolemia (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Hypercholesterolemia, familial, 1 (1)
-
-
1
Hypobetalipoproteinemia (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.15
DANN
Benign
0.73
PhyloP100
-2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28362285; hg19: chr1-55529047; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.